P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers

Cited by (129)

Items 101–129 of 129

1. Role of berberine nanoformulation in epilepsy: A novel therapeutic strategy
   Lekha Saha, Puja Kumari, Vivek Ranjan Sinha, Vipasha Gautam, Lavjot Kaur, Sunil Sharma, Amitava Chakrabarti · 2024 · Epilepsy Research
2. Effects of the chemosensitizer verapamil on P-glycoprotein substrate efflux in rainbow trout hepatocytes
   Christina U. Johnston, Christopher J. Kennedy · 2023 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology
3. Interactions between multifunctional pharmaceutical excipients and efflux pump for optimal drug transport and bioavailability: An overview
   Vinod Limbraj Gaikwad, Swati G. Sen, Pratik R. Dhake · 2024 · Journal of Drug Delivery Science and Technology
4. Involvement of P-glycoprotein and multidrug and toxin extrusion protein 1 in hepatic and renal berberine efflux in mice
   Guofeng Wang, Jingyi Jin, Jia‐Kai Zeng, Rong Shi, Yan Dai, Jiasheng Wu, Yuanyuan Li, Tianming Wang, Yueming Ma · 2017 · RSC Advances
5. Berberine mitigates neurotoxicity of misfolded protein oligomers by interacting with the cell membrane and subsequent internalization, without altering their structure.
   Silvia Errico, Giulia Fani, Martina Gennari, Alessandra Mastricci, Lorenzo Neri, Davide Odino, Claudio Canale, A. Relini, Michele Vendruscolo, B. Mannini et al. · 2025 · International Journal of Biological Macromolecules
6. Impact of Banhabaekchulcheonmatang (Banxia Baizhu Tianma Tang) and Hwangryeonhaedoktang (Huang Lian Jie Du Tang) on edoxaban: Herb-drug interaction study in healthy subjects
   Seok-jin Cho, Jungbin Song, Dong Wook Kang, Ju Hee Kim, Hocheol Kim, Hyewon Chung, Hea‐Young Cho · 2024 · Journal of Ethnopharmacology
7. Profiling the Complexity of Resistance Factors in Cancer Cells Towards Berberine and Its Derivatives
   Nadire Özenver, Nadeen T. Ali, Rümeysa Yücer, Xiao Lei, Gerhard Bringmann, Thomas Efferth, Mona Dawood · 2025 · Pharmaceuticals
8. Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines
   Ying Fan, Zhu Zhou, Lei Zhang · 2024 · Journal of Pharmacy & Pharmaceutical Sciences
9. Knockdown of the NHR-8 nuclear receptor enhanced sensitivity to the lipid-reducing activity of alkaloids in Caenorhabditis elegans
   Yit‐Lai Chow, Yuriko Kawasaki, Fumihiko Sato · 2014 · Bioscience Biotechnology and Biochemistry
10. Decreased secretory transport of a quarternary ammonium, TBuMA, across LLC-PK1 cells by the anionic kidney extract
    Won‐Sik Shim, Min‐Koo Choi, In‐Wha Kim, Tae-Sik Kwon, Im‐Sook Song, Liwei Han, Dae‐Duk Kim, Suk‐Jae Chung, Chang‐Koo Shim · 2008 · Archives of Pharmacal Research
11. Antiplasmodial activity, in silico ADME and mammalian cell cytotoxicity of a synthetic protoberberine alkaloid, coralyne
    Nekpen Erhunse, Dinkar Sahal · 2024 · Bio Research Journal/Bio- Research
12. Contribution of a significant first-pass effect of dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate in the liver to its poor bioavailability in rats
    Kyung‐Ha Yu, Ye-Rie Lee, Sung-Hoon Ahn, Dae‐Duk Kim, Chang‐Koo Shim, Suk‐Jae Chung · 2009 · Journal of Pharmacy and Pharmacology
13. Drug Transporters of Intestinal Absorption
    Yu Juan Dong · 2008 · Chinese Journal of Natural Medicines
14. Differential Effects of Red Yeast Rice, Berberis Aristata and Morus Alba Extracts, Active Components of LopiGLIK®, on PCSK9 in HepG2 Cells
    Maria Giovanna Lupo, Chiara Macchi, Silvia Marchianò, Hạixia Chen, Cesare Riccardo Sirtori, Alberto Corsini, Massimiliano Ruscica, Nicola Ferri · 2018 · Preprints.org
15. Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycemic control
    Zachary L. Sebo, Ram Prosad Chakrabarty, Rogan A. Grant, Karis B. D’Alessandro, Alec R. Koss, Jenna L. E. Blum, Shawn M. Davidson, Colleen R. Reczek, Navdeep S. Chandel · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
16. Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review
    Dumitru, Caterina Nela, Marcu, Teodora, Dumitru, Alina Oana, Tudor, Simona Steliana, Ferțu, Ionela Daniela, Elisei, Alina-Mihaela, Goroftei, Larisa · 2026 · Pharmaceuticals
17. P-Glycoprotein Inhibitors: A Review
    Shamsunnisa Shaik, Tarana Pogiri, Prathyusha Kondrothu, Sridevi Korimelli · 2022 · International Journal of Pharmaceutical Sciences Review and Research
18. The lipid-modulating effect of berberine in hyperlipidemic ApoE−/− mice
    史乃新, Xiaolei Zhou, Shengxian Wu, Yingying Zhang · 2026 · Frontiers in Pharmacology
19. Nanotechnology-driven delivery platforms overcoming the bioavailability challenges of berberine
    XiTao Chen, Wenhai Cao, Xiaotong Meng, Haitao Zhang, Ling Liu, Hanning Wang · 2026 · Industrial Crops and Products
20. Comparative Study on the Phytometabolites, in vitro Antiplasmodial Activity and Cytotoxicity of Stem Bark Extracts of Annickia affinis (Exell) Versteegh & Sosef and Annickia chlorantha (Oliv.) Setten & PJ. Mass
    Nekpen Erhunse, Dinkar Sahal · 2023 · Nigerian Journal of Life Sciences
21. Evaluation of pharmacological properties of Danshen compounds by computational and biochemical approaches
    Zhou, Zhiwei · 2016 · RMIT Research Repository (RMIT University Library)
22. Using S. cerevisiae genetic array technologies to understand mode of action of ethobotanical mycotics
    Nadereh Mir-Rashed · 2007
23. Limited Sampling Strategy of Rosuvastatin Single-Time-point Concentrations Accurately Estimate Exposure and Constitutive Transporter Activities in Healthy Adults
    Ryan Barry, Catherine Liu, Mary F. Paine, Brian Tomlinson, DAVID R. JOSEPH · 2025 · Therapeutic Drug Monitoring
24. Structure–Activity Relationship Study of Protoberberine Alkaloids Reveals Molecular Planarity as a Key Determinant of Membrane Interaction and Protection from Misfolded Protein Oligomers
    Silvia Errico, Alessandra Bigi, Giulia Fani, Monica Ambrosino, Erwan Galmiche, Francesco Bemporad, Michele Vendruscolo, Benedetta Mannini, Fabrizio Chiti · 2026 · Journal of Medicinal Chemistry
25. Metabolic and Anti-Inflammatory Effects of Berberine—Rationale for Its Therapeutic Potential in Polycystic Ovary Syndrome
    Dariusz Szukiewicz · 2026 · International Journal of Molecular Sciences
26. Berberine from Traditional Chinese Medicine in Liver Diseases: From Steatosis to Fibrosis and Hepatic Malignancies
    Hongxia He, Shuyun Wu, Jiazhi Yi · 2026 · The American Journal of Chinese Medicine
27. Berberine as a Promising Antifungal Agent: Insights into Molecular Mechanisms and Therapeutic Potential
    Junying He, Qiqi Wang, Boyan Sun, Tony Velkov, Jianzhong Shen, Haiyang Jiang, Chongshan Dai · 2026 · ACS Omega
28. The Therapeutic Potential of Berberine in Treating Diabetes and Its Complications: Molecular Mechanisms and Future Perspectives
    Yile Liao, Yu Gui, Tongyi Li, Qian Zhou, Xiangyan Chen, Huizhen Chen · 2026 · The American Journal of Chinese Medicine
29. BindingDB Entry 50002270: Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
    BindingDB · 2020 · UC San Diego